For: | Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074 [PMID: 20027679 DOI: 10.3748/wjg.15.6068] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i48/6068.htm |
Number | Citing Articles |
1 |
Iftikhar Ahmed, Faisal Fayyaz, Moneeb Nasir, Zafar Niaz, Manuele Furnari, Lorna Perry. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease – a review. Scandinavian Journal of Gastroenterology 2016; 51(4): 385 doi: 10.3109/00365521.2015.1105286
|
2 |
Seongho Kim, Xinmin Yin, Md Aminul Islam Prodhan, Xiang Zhang, Zichun Zhong, Ikuko Kato. Global Plasma Profiling for Colorectal Cancer-Associated Volatile Organic Compounds: a Proof-of-Principle Study. Journal of Chromatographic Science 2019; 57(5): 385 doi: 10.1093/chromsci/bmz011
|
3 |
Elaine Holmes, Ian D. Wilson, John C. Lindon. The Handbook of Metabolic Phenotyping. 2019; : 1 doi: 10.1016/B978-0-12-812293-8.00001-3
|
4 |
Toshiko Tanaka, Sameera A. Talegawkar, Yichen Jin, Julián Candia, Qu Tian, Ruin Moaddel, Eleanor M. Simonsick, Luigi Ferrucci. Metabolomic Profile of Different Dietary Patterns and Their Association with Frailty Index in Community-Dwelling Older Men and Women. Nutrients 2022; 14(11): 2237 doi: 10.3390/nu14112237
|
5 |
Simone Birgit Bayer, Richard Blair Gearry, Lynley Ngaio Drummond. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Critical Reviews in Food Science and Nutrition 2018; 58(14): 2432 doi: 10.1080/10408398.2017.1327841
|
6 |
Iftikhar Ahmed, Rosemary Greenwood, Ben de Lacy Costello, Norman M. Ratcliffe, Chris S. Probert, David L. Boone. An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome. PLoS ONE 2013; 8(3): e58204 doi: 10.1371/journal.pone.0058204
|
7 |
Sofie Bosch, Dion S.J. Wintjens, Alfian Wicaksono, Johan Kuijvenhoven, René van der Hulst, Pieter Stokkers, Emma Daulton, Marieke J. Pierik, James A. Covington, Tim G.J. de Meij, Nanne K.H. de Boer. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis. Digestive and Liver Disease 2020; 52(7): 745 doi: 10.1016/j.dld.2020.03.007
|
8 |
J. William Allwood, Catherine L. Winder, Warwick B. Dunn, Royston Goodacre. Methodologies for Metabolomics. 2013; : 79 doi: 10.1017/CBO9780511996634.006
|
9 |
Xiaojun Zhuang, Zhenyi Tian, Mei Luo, Lishou Xiong. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01336-6
|
10 |
Bin Feng, Jun-ho La, Erica S. Schwartz, Takahiro Tanaka, Timothy P. McMurray, G. F. Gebhart. Long-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivity. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(7): G676 doi: 10.1152/ajpgi.00490.2011
|
11 |
Kannan Ponnusamy, Jung Nam Choi, Jiyoung Kim, Sun-Young Lee, Choong Hwan Lee. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
Journal of Medical Microbiology
2011; 60(6): 817 doi: 10.1099/jmm.0.028126-0
|
12 |
Dorottya Nagy-Szakal, Dinesh K. Barupal, Bohyun Lee, Xiaoyu Che, Brent L. Williams, Ellie J. R. Kahn, Joy E. Ukaigwe, Lucinda Bateman, Nancy G. Klimas, Anthony L. Komaroff, Susan Levine, Jose G. Montoya, Daniel L. Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn, W. Ian Lipkin. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28477-9
|
13 |
Akira Tokumura. Physiological Significance of Lysophospholipids that Act on the Lumen Side of Mammalian Lower Digestive Tracts. Journal of Health Science 2011; 57(2): 115 doi: 10.1248/jhs.57.115
|
14 |
Sarah O'Flaherty, Delphine Saulnier, Bruno Pot, James Versalovic. How can probiotics and prebiotics impact mucosal immunity?. Gut Microbes 2010; 1(5): 293 doi: 10.4161/gmic.1.5.12924
|
15 |
Susanne Schiffmann, Daniela Hartmann, Sina Fuchs, Kerstin Birod, Nerea Ferreiròs, Yannick Schreiber, Aleksandra Zivkovic, Gerd Geisslinger, Sabine Grösch, Holger Stark. Inhibitors of specific ceramide synthases. Biochimie 2012; 94(2): 558 doi: 10.1016/j.biochi.2011.09.007
|
16 |
Xiaojun Zhang, Franky F. K. Choi, Yan Zhou, Feung P. Leung, Shun Tan, Shuhai Lin, Hongxi Xu, Wei Jia, Joseph J. Y. Sung, Zongwei Cai, Zhaoxiang Bian. Metabolite profiling of plasma and urine from rats with TNBS‐induced acute colitis using UPLC‐ESI‐QTOF‐MS‐based metabonomics – a pilot study. The FEBS Journal 2012; 279(13): 2322 doi: 10.1111/j.1742-4658.2012.08612.x
|
17 |
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
|
18 |
Maciej Danielewski, Dorota Ksiądzyna, Adam Szeląg. NON-ANTIBIOTIC USE OF ANTIBIOTICS. Postępy Mikrobiologii - Advancements of Microbiology 2018; 57(4): 301 doi: 10.21307/PM-2018.57.4.301
|
19 |
Takaaki Matsufuji, Masanao Kinoshita, Anna Möuts, J. Peter Slotte, Nobuaki Matsumori. Preparation and Membrane Properties of Oxidized Ceramide Derivatives. Langmuir 2018; 34(1): 465 doi: 10.1021/acs.langmuir.7b02654
|
20 |
Jia-Qian Chen, Yan-Yan Chen, Hui-Juan Tao, Zong-Jin Pu, Xu-Qin Shi, Jing Zhang, Ya-Jie Tan, Shi-Jun Yue, Gui-Sheng Zhou, Er-Xin Shang, Yu-Ping Tang, Jin-Ao Duan. An integrated metabolomics strategy to reveal dose-effect relationship and therapeutic mechanisms of different efficacy of rhubarb in constipation rats. Journal of Pharmaceutical and Biomedical Analysis 2020; 177: 112837 doi: 10.1016/j.jpba.2019.112837
|
21 |
Bin Feng, Jun Ho La, Erica S. Schwartz, G. F. Gebhart. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(10): G1085 doi: 10.1152/ajpgi.00542.2011
|
22 |
Valencia Ru‐Yan Zhang, Gokula Krishnan Ramachandran, Evelyn Xiu Ling Loo, Alex Yu Sen Soh, Wei Peng Yong, Kewin Tien Ho Siah. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review. Neurogastroenterology & Motility 2023; 35(7) doi: 10.1111/nmo.14536
|
23 |
Timon Eckes, Sandra Trautmann, Sonja Djudjaj, Sandra Beyer, Sammy Patyna, Stephanie Schwalm, Stefan Gauer, Dominique Thomas, Liliana Schaefer, Peter Boor, Alexander Koch, Josef Pfeilschifter. Consistent alteration of chain length-specific ceramides in human and mouse fibrotic kidneys. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2021; 1866(1): 158821 doi: 10.1016/j.bbalip.2020.158821
|
24 |
Anna Caretti, Alessandra Bragonzi, Marcella Facchini, Ida De Fino, Camilla Riva, Paolo Gasco, Claudia Musicanti, Josefina Casas, Gemma Fabriàs, Riccardo Ghidoni, Paola Signorelli. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1): 586 doi: 10.1016/j.bbagen.2013.10.018
|
25 |
Iftikhar Ahmed, Zafar Niaz, Frederick Ewbank, Danyal Akarca, Richard Felwick, Manuele Furnari. Sniffing Out Causes of Gastrointestinal Disorders: A Review of Volatile Metabolomic Biomarkers. Biomarkers in Medicine 2018; 12(10): 1139 doi: 10.2217/bmm-2018-0074
|
26 |
Jie Chen, Tingting Zhao, Hongfei Li, Wanli Xu, Kendra Maas, Vijender Singh, Ming-Hui Chen, Susan G. Dorsey, Angela R. Starkweather, Xiaomei S. Cong. Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome. International Journal of Molecular Sciences 2024; 25(6): 3514 doi: 10.3390/ijms25063514
|
27 |
Per Venge, Valeria Castro Tejera, Christer Petersson, Shengyuan Xu, Anders Larsson, Magnus Simrén, Lena Öhman, Hans Törnblom. Elevated Fecal Biomarkers of Colo‐Rectal Epithelial Cell Activity in Irritable Bowel Syndrome. Neurogastroenterology & Motility 2024; doi: 10.1111/nmo.14984
|
28 |
Sabine Grösch, Susanne Schiffmann, Gerd Geisslinger. Chain length-specific properties of ceramides. Progress in Lipid Research 2012; 51(1): 50 doi: 10.1016/j.plipres.2011.11.001
|
29 |
Aihua Zhang, Hui Sun, Ping Wang, Ying Han, Xijun Wang. Modern analytical techniques in metabolomics analysis. The Analyst 2012; 137(2): 293 doi: 10.1039/C1AN15605E
|
30 |
Charu Gupta. Natural Useful Therapeutic Products from Microbes. Journal of Microbiology & Experimentation 2014; 1(1) doi: 10.15406/jmen.2014.01.00006
|
31 |
Karl Fraser, Shanalee C. James, Wayne Young, Richard B. Gearry, Phoebe E. Heenan, Jacqueline I. Keenan, Nicholas J. Talley, Warren C. McNabb, Nicole C. Roy. Characterisation of the Plasma and Faecal Metabolomes in Participants with Functional Gastrointestinal Disorders. International Journal of Molecular Sciences 2024; 25(24): 13465 doi: 10.3390/ijms252413465
|
32 |
Lufang Chen, Keying Xu, Qifeng Gui, Yue Chen, Deying Chen, Yunmei Yang. Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis. Experimental and Therapeutic Medicine 2016; 12(3): 1836 doi: 10.3892/etm.2016.3534
|
33 |
Aaron I. Gardner, Iram J. Haq, A. John Simpson, Katrin A. Becker, John Gallagher, Vinciane Saint-Criq, Bernard Verdon, Emily Mavin, Alexandra Trigg, Michael A. Gray, Albert Koulman, Melissa J. McDonnell, Andrew J. Fisher, Elizabeth L. Kramer, John P. Clancy, Christopher Ward, Edward H. Schuchman, Erich Gulbins, Malcolm Brodlie. Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine 2020; 202(8): 1133 doi: 10.1164/rccm.202001-0180OC
|
34 |
Martin F. Almstetter, Peter J. Oefner, Katja Dettmer. Comprehensive two-dimensional gas chromatography in metabolomics. Analytical and Bioanalytical Chemistry 2012; 402(6): 1993 doi: 10.1007/s00216-011-5630-y
|
35 |
Natalia Zeber-Lubecka, Maria Kulecka, Filip Ambrozkiewicz, Agnieszka Paziewska, Krzysztof Goryca, Jakub Karczmarski, Tymon Rubel, Wojciech Wojtowicz, Piotr Mlynarz, Lukasz Marczak, Roman Tomecki, Michal Mikula, Jerzy Ostrowski. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes 2016; 7(5): 397 doi: 10.1080/19490976.2016.1215805
|
36 |
Antonella Orlando, Valeria Tutino, Maria Notarnicola, Giuseppe Riezzo, Michele Linsalata, Caterina Clemente, Laura Prospero, Manuela Martulli, Benedetta D’Attoma, Valentina De Nunzio, Francesco Russo. Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective. Nutrients 2020; 12(6): 1652 doi: 10.3390/nu12061652
|
37 |
Xijun Wang, Hui Sun, Aihua Zhang, Ping Wang, Ying Han. Ultra‐performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. Journal of Separation Science 2011; 34(24): 3451 doi: 10.1002/jssc.201100333
|
38 |
Kamesh Gupta, Harparam Singh Ghuman, Shivani Vijay Handa. Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile. Clinical Medicine Insights: Gastroenterology 2017; 10: 117955221772890 doi: 10.1177/1179552217728905
|
39 |
M. Pimentel. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Alimentary Pharmacology & Therapeutics 2016; 43(S1): 37 doi: 10.1111/apt.13437
|